Karen Lam, PhD
Chief Executive Officer, Co-Founder
Molecular biology, diagnostics
development and commercialization
Information gathered at the biomolecular level, from tens of thousands of genes, proteins, metabolites, microbes (see capabilities below)
State-of-the-art data analytics that generate high-resolution health and disease "fingerprints" for each pet, based on its unique molecular profile
Breaking barriers and working across sectors and disciplines to solve problems in veterinary health - together
Microarrays, next-generation sequencing, targeted gene expression
Mass spectrometry, immuno-assays, other targeted protein assays
Nuclear magnetic resonance (NMR), mass spectrometry
DNA methylation arrays (e.g., Illumina EPIC and 450K)
Flow cytometry, complete blood counts, single cell sequencing
Blood chemistry, physiologic data, treatment, pathology, Imaging (e.g., ultrasound, CT, X-ray),